RE:Another interesting SPIE conference on PDT in Jan. 2019 ...You shiiitttin me, right, Bbbenny, you are already pushin the conferences next January?? What happenned at the ones hyou were pushin this past January???? You pumped those for months and then no comment on them when they occured, WHAT HAPPENED, BBBENNY???
NOW IN MARCH U START PUMPIN FOR NEXT JANUARY???
You have no shame either, bbbenny! You really think the lemmings have such short memories?? Guess he thinks they do!!! But i dont, you deceiving, low life scummie!!!
Tell us about the ones that just ended after the new year, bbenny?? WHAT HAPPENED, AND THE HAMBURGHER VIDEO, AND ALL THE OTHER BS, LIKE A PP COMING!! SCUMMIE!!!
bencro wrote: This will be another interesting one to present to:
The Moscone Center
San Francisco, California, United States
2 - 7 February 2019
Abstract Due:
25 July 2018
Author Notification:
1 October 2018
Manuscript Due Date:
11 January 2019
Photodynamic therapy (PDT) has been approved by health agencies in several countries for treatment of neoplasia in a variety of sites and has been used for treatment of other pathologic conditions including actinic keratosis, atherosclerosis, and age related macular degeneration (AMD). PDT can be used to target different subcellular sites for photodamage, e.g., the endoplasmic reticulum, lysosomes, mitochondria, and the plasma membrane. Photodamage can elicit cell death by activation of apoptosis, circumventing many common modes of drug resistance.
This conference will emphasize drug development, mechanisms, clinical applications, instrumentation for light delivery and dosimetry determinations along with new information on photodynamic mechanisms.
Abstracts are encouraged dealing with these topics: - drug development and characterization
- clinical protocols and outcomes
- mechanisms of phototoxicity
- techniques for light delivery and dosimetry
- tissue optics.
Special Joint Symposium: Optical and Ionizing Radiation Interactions for Diagnosis and Therapy
Optical and Ionizing radiation interactions have a long history of research and development together with a growing importance in areas of radiation therapy, radiobiology, nuclear medicine, nanotechnology, theranostics, biological physics, and biophysics. Diagnostic uses include in vitro and in vivo assays along with hybrid modality-, radiotherapy- and diagnostic nuclear medicine imaging. Therapeutic uses include radiation therapy sensitization, photodynamic activation and nanoparticle mediated therapies. The basic components of this field involve radiation transport modeling, radiobiology, dosimetry, radiometry, medicinal chemistry, liposome/ micelle design and applicable disease models.